Novartis AG to buy experimental oral drug of Pikavation for $3 billion
Novartis AG has agreed to buy an investigational oral medicine of Pikavation Therapeutics, a subsidiary of privately-held Synnovation Therapeutics, to treat breast cancer, for.
Drugs
Medical
Pharma
Health
Medical
Pharma
Roche expands artificial intelligence deployment in pact with Nvidia
Switzerland’s F. Hoffmann-La Roche AG upgraded its artificial intelligence infrastructure by deploying Nvidia’s technology to accelerate development of diagnostic solutions and therapeutics.
Health
Pharma
Research
UN says 4.9 million children died before fifth birthday two years ago
About 4.9 million children died before their fifth birthday in 2024, including 2.3 million newborns, according to a UN report.
Drugs
Pharma
Eli Lilly sounds alarm on counterfeit weight-loss drugs mixed with vitamin B12
HQ Staff Writer March 13, 2026: Eli Lily, the pharmaceutical giant, has warned that compounded versions of its blockbuster weight-loss drug tirzepatide, when.
Health
Pharma
Research
WHO says 7.1 million people’s cancers are preventable each year
Nearly 37% of all new cancers or 7.1 million cases could be prevented each year, according to a report by the World Health.
Drugs
Pharma
Pill for frontotemporal dementia clears safety milestone
HQ Team 27 November, 2025: A new once-a-day pill designed to stop frontotemporal dementia (FTD) has cleared its first major safety test, researchers.
Drugs
Pharma
Research
India superbug crisis: 83% carry antibiotic-resistant bacteria, Lancet study
HQ Team November 19, 2025: An international study published in The Lancet’s eClinicalMedicine journal has exposed the devastating scale of India’s antimicrobial resistance.
Drugs
Pharma
Global drug supply relies heavily on China and India, warn reports
HQ Team October 31, 2025: A new German study reveals that Europe is significantly dependent on China for essential medicines and their chemical components..
Drugs
Health
Pharma
AstraZeneca, Amgen’s drug for nasal inflammation gets EU nod
The European Union approved AstraZeneca Plc and Amgen Inc.’s add-on therapy to treat adults with a chronic inflammatory condition of the nasal passages.
Drugs
Health
Pharma
China’s Innovent, Japan’s Takeda in $11.4 billion deal for cancer therapies
China’s Innovent Biologics and Takeda Pharmaceutical Co. announced a $11.4 billion licensing deal, which will enable the former to speed up the development.